CAS 2222635-92-7

Fórmula: C35H35FN6O6

InChI: InChI=1S/C35H35FN6O6/c1-18-26(17-23-22-16-20(36)10-11-24(22)40-31(23)44)39-19(2)29(18)33(46)38-15-6-4-3-5-14-37-25-9-7-8-21-30(25)35(48)42(34(21)47)27-12-13-28(43)41-32(27)45/h7-11,16-17,27,37,39H,3-6,12-15H2,1-2H3,(H,38,46)(H,40,44)(H,41,43,45)/b23-17-

Clave InChI: VXBLUAKQWQJPAD-QJOMJCCJSA-N

SMILES: CC1=C(NC(=C1C(=O)NCCCCCCNC2=CC=CC3=C2C(=O)N(C3=O)C4CCC(=O)NC4=O)C)/C=C\5/C6=C(C=CC(=C6)F)NC5=O

MI-389

CAS: 2222635-92-7

MI-389

Fórmula: C₃₅H₃₅FN₆O₆

Pureza: ≥98%

Peso molecular: 654.69

Ref: 54-BUP21077

MI-389

CAS: 2222635-92-7

Fórmula: C₃₅H₃₅FN₆O₆

Peso molecular: 654.6874

Ref: IN-DA0249X2

MI-389

CAS: 2222635-92-7

(Z)-N-(6-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)hexyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide

Fórmula: C₃₅H₃₅FN₆O₆

Pureza: 98%

Peso molecular: 654.69

Ref: IN-DG01466395

MI-389

CAS: 2222635-92-7

MI-389 is a PROTAC degrader that induces the degradation of receptor tyrosine kinases (RTKs), useful for leukemia research.

Fórmula: C₃₅H₃₅FN₆O₆

Pureza: 98.12%

Forma y color: Solid

Peso molecular: 654.69

Ref: TM-T33380